Volume 22, Number 10—October 2016
Dispatch
Persistence of Antibodies against Middle East Respiratory Syndrome Coronavirus
Table
Characteristics of Middle East respiratory syndrome patients and antibody titers at 13 and 34 months after 2012 outbreak, Jordan*
Patient no. | Age, y/sex | Underlying condition | Intensive care | Days hospitalized | Chest radiograph† | 13-mo titer‡ |
34-mo titer‡ |
|||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
ELISA | IFA | MN | ELISA | IFA | MN | |||||||
02 | 31/M | Atrial septal defect | Yes | 16 | Right lobar pneumonia | >6,400 | Pos | 160 | 1,600 | Pos | 80 | |
03§ | 60/M | Hypertension | NA | NA | Bilateral consolidation; pneumonia | 400 | Pos | 20 | <400 | Ind | 20 | |
04 | 35/M | Hypertension | Yes | 8 | Bilateral lobar pneumonia | >6,400 | Pos | 80 | 400 | Pos | 40 | |
06 | 46/M | None reported | No | 6 | Right bronchial congestion with bronchovascular markings | 1,600 | Pos | 20 | 1,600 | Pos | 20 | |
09 | 45/M | None reported | No | 10 | Left consolidation; right infiltrate | 400 | Pos | 40 | <400 | Neg | 40 | |
11¶ | 41/F | None reported | No | 4 | ND | 1,600 | Pos | <20 | 400 | Neg | <20 | |
HH303§ | 39/F | Pregnant | NA | NA | NA | 1,600 | Pos | 80 | 400 | Pos | 80 |
*IFA, immunofluorescence assay; Ind, indeterminate; MN, microneutralization assay; NA, not applicable; ND, not documented; neg, negative; pos, positive.
†Taken within 3 days of presentation.
‡Antibodies against Middle East respiratory syndrome coronavirus.
§Symptomatic but refused hospitalization.
¶Classified overall as being serologically negative at 34 mo.